These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11691582)

  • 41. Production of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human breast carcinomas.
    Iwata H; Kobayashi S; Iwase H; Masaoka A; Fujimoto N; Okada Y
    Jpn J Cancer Res; 1996 Jun; 87(6):602-11. PubMed ID: 8766524
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Matrilysin over-expression in MCF-7 cells enhances cellular invasiveness and pro-gelatinase activation.
    Wang F; Reierstad S; Fishman DA
    Cancer Lett; 2006 May; 236(2):292-301. PubMed ID: 16019136
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Roles of membrane type 1 matrix metalloproteinase and tissue inhibitor of metalloproteinases 2 in invasion and dissemination of human malignant glioma.
    Nakada M; Kita D; Futami K; Yamashita J; Fujimoto N; Sato H; Okada Y
    J Neurosurg; 2001 Mar; 94(3):464-73. PubMed ID: 11235952
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Zymographic detection and clinical correlations of MMP-2 and MMP-9 in breast cancer sera.
    La Rocca G; Pucci-Minafra I; Marrazzo A; Taormina P; Minafra S
    Br J Cancer; 2004 Apr; 90(7):1414-21. PubMed ID: 15054465
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Zymographic analysis and characterization of MMP-2 and -9 forms in human sound dentin.
    Mazzoni A; Mannello F; Tay FR; Tonti GA; Papa S; Mazzotti G; Di Lenarda R; Pashley DH; Breschi L
    J Dent Res; 2007 May; 86(5):436-40. PubMed ID: 17452564
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Low circulating levels of ProMMP-2 are associated with adverse prognosis in bladder cancer.
    Vasala K; Kuvaja P; Turpeenniemi-Hujanen T
    Tumour Biol; 2008; 29(5):279-86. PubMed ID: 18802398
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The activation of matrix metalloproteinases by a whole-cell extract from Prevotella nigrescens.
    Itoh T; Nakamura H; Kishi J; Hayakawa T
    J Endod; 2009 Jan; 35(1):55-9. PubMed ID: 19084125
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Proteolytic roles of matrix metalloproteinase (MMP)-13 during progression of chronic periodontitis: initial evidence for MMP-13/MMP-9 activation cascade.
    Hernández Ríos M; Sorsa T; Obregón F; Tervahartiala T; Valenzuela MA; Pozo P; Dutzan N; Lesaffre E; Molas M; Gamonal J
    J Clin Periodontol; 2009 Dec; 36(12):1011-7. PubMed ID: 19929954
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Protein expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinase 1 and 2 in papillary thyroid carcinomas.
    Maeta H; Ohgi S; Terada T
    Virchows Arch; 2001 Feb; 438(2):121-8. PubMed ID: 11253113
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gelatinase A, membrane type 1 matrix metalloproteinase, and extracellular matrix metalloproteinase inducer mRNA expression: correlation with invasive growth of breast cancer.
    Dalberg K; Eriksson E; Enberg U; Kjellman M; Bäckdahl M
    World J Surg; 2000 Mar; 24(3):334-40. PubMed ID: 10658069
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use of gel zymography to examine matrix metalloproteinase (gelatinase) expression in brain tissue or in primary glial cultures.
    Frankowski H; Gu YH; Heo JH; Milner R; Del Zoppo GJ
    Methods Mol Biol; 2012; 814():221-33. PubMed ID: 22144310
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Circulating gelatinase B (MMP-9)--the impact of the preanalytical step of blood collection.
    Jung K; Lein M; Roemer A; Lichtinghagen R
    Matrix Biol; 2002 Aug; 21(5):381-2. PubMed ID: 12225801
    [No Abstract]   [Full Text] [Related]  

  • 53. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
    Bigg HF; Morrison CJ; Butler GS; Bogoyevitch MA; Wang Z; Soloway PD; Overall CM
    Cancer Res; 2001 May; 61(9):3610-8. PubMed ID: 11325829
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of complexes of gelatinase A and tissue inhibitor of metalloproteinase-2 in human follicular fluid.
    Shimokawa KI; Katayama M; Matsuda Y; Takahashi H; Hara I; Sato H
    Reprod Med Biol; 2003 Sep; 2(3):115-119. PubMed ID: 29662377
    [No Abstract]   [Full Text] [Related]  

  • 55. Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface.
    Lehti K; Lohi J; Valtanen H; Keski-Oja J
    Biochem J; 1998 Sep; 334 ( Pt 2)(Pt 2):345-53. PubMed ID: 9716492
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Matrix metalloproteinase 2 and 9 activity in patients with colorectal cancer liver metastasis.
    Waas ET; Wobbes T; Lomme RM; DeGroot J; Ruers T; Hendriks T
    Br J Surg; 2003 Dec; 90(12):1556-64. PubMed ID: 14648736
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of plasma activity of matrix metalloproteinase-2 and -9 in dogs with myxomatous mitral valve disease.
    Ljungvall I; Rajamäki MM; Crosara S; Olsen LH; Kvart C; Borgarelli M; Höglund K; Häggström J
    Am J Vet Res; 2011 Aug; 72(8):1022-8. PubMed ID: 21801058
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Matrix metalloproteinase-2 and -9 activities in human keloids, hypertrophic and atrophic scars: a pilot study.
    Tanriverdi-Akhisaroglu S; Menderes A; Oktay G
    Cell Biochem Funct; 2009 Mar; 27(2):81-7. PubMed ID: 19165813
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Front-cell-specific expression of membrane-type 1 matrix metalloproteinase and gelatinase A during cohort migration of colon carcinoma cells induced by hepatocyte growth factor/scatter factor.
    Nabeshima K; Inoue T; Shimao Y; Okada Y; Itoh Y; Seiki M; Koono M
    Cancer Res; 2000 Jul; 60(13):3364-9. PubMed ID: 10910039
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dimerization of endogenous MT1-MMP is a regulatory step in the activation of the 72-kDa gelatinase MMP-2 on fibroblasts and fibrosarcoma cells.
    Ingvarsen S; Madsen DH; Hillig T; Lund LR; Holmbeck K; Behrendt N; Engelholm LH
    Biol Chem; 2008 Jul; 389(7):943-53. PubMed ID: 18627313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.